UnitedHealth Group (UNH) PT Raised to $410 at Leerink Partners

Leerink Partners analyst Whit Mayo raised the price target on UnitedHealth Group (NYSE: UNH) to $410.00 (from $402.00) while maintaining a Outperform rating.

The analyst comments "Bottom Line: Reiterate Outperform rating. 3Q25 results brought forth good execution against lowered targets, stable (yet elevated) trend and forward commentary that lays compelling groundwork to believe in a multi-year margin recovery thesis. We still see an interesting upside case for $25/share in EPS for 2027 w/ tremendous embedded earnings power if UNH's underpinning assumptions are believable or too low. Valuation doesn't strike us as overly compelling given the run-up and squared against peer multiples, yet we think the stock can move up with: (1) better execution/numbers; (2) more clarity on V28 hurdles and (3) improving/stable cost trends."

You May Also Be Interested In

• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August